Shuqun Zhang

CURRICULUM VITAE

Shuqun Zhang, MD, Ph.D.

Personal

Place of Birth: Changchun, Jilin Province, China

Date of Birth: April 10, 1971

Current work address: Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province 710004, China.

Email: shuqun_zhang1971@163.com, zhangshuqun1971@aliyun.com

Education and Professional appointments

1989.09-1994.07 Bachelor's degree of Clinical Medicine, Xi'an Medical University

1994.07-1999.07 Resident of General Surgery, the Second Affiliated Hospital of Xi'an Medical University

1996.09-1999.07 Master's degree of General Surgery, Xi'an Medical University

1999.07-2001.06 Resident of Oncology Surgery, the Second Affiliated Hospital of Xi'an Medical University

2001.07-2010.01 Attending doctor of Surgical Oncology, the Second Affiliate Hospital of Xi'an Medical University

2001.09-2004.11 Doctor’s degree of Surgical Oncology, Medical School of Xi'an Jiaotong University

2010.01-2014.12 Associate chief physician of Oncology Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University

2014.12 at pres. Chief physician of Oncology Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University

2011.03-2017.01 Director of Medical Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University

2017.01 at pres. Vice president of Oncology Hospital and Director of Oncology Department, the Second Affiliated Hospital of Xi'an Jiaotong University

2017.01 at pres. Director of Oncology, the Second Clinical Medical College of Xi'an Jiaotong University

Academic appointments

· Vice director of Oncology Health Care Quality Control Center, Shaanxi Health Commission

· Cooperative doctoral supervisor with the University of Texas MD Anderson Cancer Center, US.

· Chairman of Breast Cancer Committee of Shaanxi Anti-cancer Association

· Chairman of Breast Cancer Committee of Xi’an Caner Recovery Association

· Vice chairman of Breast Cancer Committee of Chinese Medical and Pharmaceutical Education Association

· Executive member of the Precision Cancer Treatment Committee, World Federation of Chinese Medicine Societies

· Vice chairman of Breast and Thyroid Specialists Committee of Shaanxi Medical Doctor Association

· Vice chairman of Precision Treatment Committee of Shaanxi Anti-cancer Association

· Vice chairman of Chemotherapy Committee of Shaanxi Anti-cancer Association

Prof. Zhang has been devoted in the clinical practice, education and research work in the tumor fields for more than 30 years. She is familiar with the frontiers and development of cancer treatment as well as cancer-associated scientific research worldwide. As for clinical work, she always advocates the comprehensive, standardized, personalized therapy for every cancer patients. She has built up lots of experiences and been the leading specialists in the diagnosis and treatment of various cancer, especially breast cancer. Oncology department of the Second Affiliated Hospital of Xi'an Jiaotong University has become the largest center for breast diseases under her guidance.

Prof. Zhang has directed more than 20 national and provincial scientific research projects with funds over three million. She also participated in many national “863”, “973” core scientific projects and other major international researches. She has been leading her own cancer research team composed of more than 50 graduates and Ph.d students and published more than 50 articles, many of which were included in international journals of high level, such as Nature series. The total impact factor score is over 100. She also encourages and promotes international research cooperation with top universities abroad.

The major research directions:

1. the molecular biological mechanisms involved in oncogenesis, early diagnosis and treatment of breast cancer.

2. Epidemic analysis of cancer associated genes and exploration novel tumor targets.

3. Construction of cancer organoid platform for personalized treatment, drug screening and cancer associated research.

4. Basic study of cancer immunology, tumor microenvironment and preclinical model of novel caner immunotherapy.

5. Effects of traditional Chinese herbal medicine on malignant tumors and its potential mechanisms.